Prestige Consumer Healthcare Inc. (PBH) · Insider trading

What Prestige Consumer Healthcare's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months

0 insiders, 0 trades

Sold, 12 months

$424,424

2 insiders, 27% under a plan

Net, 12 months

−$424,424

bought less sold

Latest filing

2026-08-05

filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

Bought Sold Largest month: $12.00M

Who traded, two years

Insider	Bought	Sold	Trades	Last trade	Holds after
Lombardi Ronald M.Director, Chief Executive Officer	–	$7.69M	4	2024-11-19	320,952
Sacco ChristineChief Financial Officer	–	$2.02M	1	2024-11-12	30,123
Mekhail AdelEVP, Marketing & Sales	–	$1.70M	3	2025-02-11	18,365
Fritz Mary BethSVP Quality & Regulatory	–	$1.50M	4	2025-03-10	17,157
P'Pool WilliamSee Remarks	–	$735,586	1	2024-11-12	20,058
Zerillo JeffreySenior VP Operations	–	$246,374	7	2026-05-11	41,810
Byom John eDirector	–	$178,050	1	2025-11-25	51,594

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

Date	Insider	Trade	Shares	Price	Value	Holds after	Filing
2026-05-11	Zerillo JeffreySenior VP Operations	Saleplan	351	52.28	$18,350	41,810	Form 4
2026-05-07	Zerillo JeffreySenior VP Operations	Saleplan	305	54.36	$16,580	42,161	Form 4
2026-05-05	Zerillo JeffreySenior VP Operations	Sale	1,207	54.99	$66,373	42,820	Form 4
2026-05-05	Zerillo JeffreySenior VP Operations	Saleplan	346	55.32	$19,141	44,334	Form 4
2026-02-11	Zerillo JeffreySenior VP Operations	Sale	1,000	65.93	$65,930	41,048	Form 4
2025-12-01	Zerillo JeffreySenior VP Operations	Saleplan	281	60.00	$16,860	42,048	Form 4
2025-11-28	Zerillo JeffreySenior VP Operations	Saleplan	719	60.00	$43,140	42,329	Form 4
2025-11-25	Byom John eDirector	Sale	3,000	59.35	$178,050	51,594	Form 4
2025-03-10	Fritz Mary BethSVP Quality & Regulatory	Saleplan	1,678	90.00	$151,020	17,157	Form 4
2025-03-03	Fritz Mary BethSVP Quality & Regulatory	Saleplan	6,297	85.39	$537,701	18,835	Form 4
2025-02-11	Mekhail AdelEVP, Marketing & Sales	Sale	5,400	86.82	$468,828	18,365	Form 4
2025-02-11	Mekhail AdelEVP, Marketing & Sales	Sale	5,683	86.30	$490,443	18,365	Form 4
2024-11-19	Lombardi Ronald M.Director, Chief Executive Officer	Sale	5,213	82.55	$430,333	320,952	Form 4
2024-11-19	Lombardi Ronald M.Director, Chief Executive Officer	Sale	5,662	82.64	$467,908	320,952	Form 4
2024-11-18	Lombardi Ronald M.Director, Chief Executive Officer	Sale	48,512	82.67	$4.01M	320,952	Form 4
2024-11-18	Lombardi Ronald M.Director, Chief Executive Officer	Sale	33,725	82.41	$2.78M	320,952	Form 4
2024-11-12	Fritz Mary BethSVP Quality & Regulatory	Sale	6,471	81.99	$530,557	18,835	Form 4
2024-11-12	Fritz Mary BethSVP Quality & Regulatory	Sale	3,414	81.93	$279,709	18,835	Form 4
2024-11-12	Mekhail AdelEVP, Marketing & Sales	Sale	9,063	82.00	$743,166	18,365	Form 4
2024-11-12	Sacco ChristineChief Financial Officer	Sale	24,686	82.01	$2.02M	30,123	Form 4
2024-11-12	P'Pool WilliamSee Remarks	Sale	8,987	81.85	$735,586	20,058	Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

40 × shares withheld for tax35 × grant or award9 × option exercise2 × gift

Show them

Date	Insider	What	Shares	Price	Holds after	Filing
2026-08-04	Byom John eDirector	Grant or award A	+2,981	–	54,575	Form 4
2026-08-04	Clark Celeste A.Director	Grant or award A	+2,981	–	16,511	Form 4
2026-08-04	DArecca JamesDirector	Grant or award A	+2,981	–	9,572	Form 4
2026-08-04	Kelly John F.Director	Grant or award A	+2,981	–	7,832	Form 4
2026-08-04	Zier Dawn M.Director	Grant or award A	+2,981	–	19,514	Form 4
2026-05-07	Mekhail AdelEVP, Marketing & Sales	Shares withheld for tax F	−487	54.59	25,703	Form 4
2026-05-07	Lombardi Ronald M.Director, Chief Executive Officer	Shares withheld for tax F	−2,543	54.59	373,465	Form 4
2026-05-07	Sacco ChristineCFO & COO	Shares withheld for tax F	−991	54.59	71,636	Form 4
2026-05-07	Zerillo JeffreySenior VP Operations	Shares withheld for tax F	−351	54.59	42,466	Form 4
2026-05-05	Lombardi Ronald M.Director, Chief Executive Officer	Shares withheld for tax F	−2,197	55.75	376,008	Form 4
2026-05-05	Sacco ChristineCFO & COO	Shares withheld for tax F	−1,267	55.75	72,627	Form 4
2026-05-05	Zerillo JeffreySenior VP Operations	Shares withheld for tax F	−307	55.75	44,027	Form 4
2026-05-04	Lombardi Ronald M.Director, Chief Executive Officer	Grant or award A	+31,468	–	375,332	Form 4
2026-05-04	Lombardi Ronald M.Director, Chief Executive Officer	Shares withheld for tax F	−16,789	55.31	358,543	Form 4
2026-05-04	Lombardi Ronald M.Director, Chief Executive Officer	Grant or award A	+19,662	–	378,205	Form 4
2026-05-04	Mekhail AdelEVP, Marketing & Sales	Grant or award A	+3,505	–	23,871	Form 4
2026-05-04	Mekhail AdelEVP, Marketing & Sales	Shares withheld for tax F	−1,695	55.31	22,176	Form 4
2026-05-04	Mekhail AdelEVP, Marketing & Sales	Grant or award A	+4,014	–	26,190	Form 4
2026-05-04	Zerillo JeffreySenior VP Operations	Grant or award A	+2,450	–	43,066	Form 4
2026-05-04	Zerillo JeffreySenior VP Operations	Shares withheld for tax F	−1,243	55.31	41,823	Form 4
2026-05-04	Zerillo JeffreySenior VP Operations	Grant or award A	+2,857	–	44,680	Form 4
2026-05-04	P'Pool WilliamSee Remarks	Grant or award A	+3,675	–	25,850	Form 4
2026-05-04	P'Pool WilliamSee Remarks	Shares withheld for tax F	−1,888	55.31	23,962	Form 4
2026-05-04	P'Pool WilliamSee Remarks	Grant or award A	+4,187	–	28,149	Form 4
2026-05-04	Sacco ChristineCFO & COO	Grant or award A	+7,008	–	65,352	Form 4
2026-05-04	Sacco ChristineCFO & COO	Shares withheld for tax F	−3,434	55.31	61,918	Form 4
2026-05-04	Sacco ChristineCFO & COO	Grant or award A	+11,976	–	73,894	Form 4
2026-05-02	Sacco ChristineCFO & COO	Shares withheld for tax F	−1,091	55.09	57,374	Form 4/A
2026-05-02	P'Pool WilliamSee Remarks	Shares withheld for tax F	−599	55.09	22,175	Form 4
2026-05-02	Mekhail AdelEVP, Marketing & Sales	Shares withheld for tax F	−542	55.09	20,366	Form 4
2026-05-02	Lombardi Ronald M.Director, Chief Executive Officer	Shares withheld for tax F	−2,665	55.09	343,864	Form 4
2026-05-02	Zerillo JeffreySenior VP Operations	Shares withheld for tax F	−432	55.09	40,616	Form 4
2026-01-06	Rosado Jose LuisSee Remarks	Grant or award A	+3,426	–	3,436	Form 4
2025-08-05	Byom John eDirector	Grant or award A	+2,094	–	54,594	Form 4
2025-08-05	Clark Celeste A.Director	Grant or award A	+2,094	–	13,530	Form 4
2025-08-05	DArecca JamesDirector	Grant or award A	+2,094	–	6,591	Form 4
2025-08-05	Hopkins SheilaDirector	Grant or award A	+2,094	–	30,123	Form 4
2025-08-05	Zier Dawn M.Director	Grant or award A	+2,094	–	16,533	Form 4
2025-08-05	Kelly John F.Director	Grant or award A	+2,094	–	4,851	Form 4
2025-05-07	Fritz Mary BethSVP Quality & Regulatory	Shares withheld for tax F	−315	81.41	17,051	Form 4
2025-05-07	Zerillo JeffreySenior VP Operations	Shares withheld for tax F	−354	81.41	43,048	Form 4
2025-05-07	Sacco ChristineCFO & COO	Shares withheld for tax F	−990	81.41	58,465	Form 4/A
2025-05-07	Mekhail AdelEVP, Marketing & Sales	Shares withheld for tax F	−457	81.41	20,908	Form 4
2025-05-07	Lombardi Ronald M.Director, Chief Executive Officer	Shares withheld for tax F	−2,305	81.41	346,529	Form 4
2025-05-05	Sacco ChristineCFO & COO	Grant or award A	+7,775	–	59,455	Form 4/A
2025-05-05	Zerillo JeffreySenior VP Operations	Grant or award A	+1,837	–	43,402	Form 4
2025-05-05	Lombardi Ronald M.Director, Chief Executive Officer	Grant or award A	+12,352	–	348,834	Form 4
2025-05-05	Mekhail AdelEVP, Marketing & Sales	Grant or award A	+2,622	–	21,365	Form 4
2025-05-05	P'Pool WilliamSee Remarks	Grant or award A	+2,709	–	22,774	Form 4
2025-05-05	Zerillo JeffreySenior VP Operations	Grant or award A	+1,725	–	42,430	Form 4
2025-05-05	Zerillo JeffreySenior VP Operations	Shares withheld for tax F	−865	82.98	41,565	Form 4
2025-05-05	Sacco ChristineCFO & COO	Shares withheld for tax F	−2,415	82.98	51,680	Form 4
2025-05-05	Mekhail AdelEVP, Marketing & Sales	Grant or award A	+2,464	–	19,861	Form 4
2025-05-05	Mekhail AdelEVP, Marketing & Sales	Shares withheld for tax F	−1,118	82.98	18,743	Form 4
2025-05-05	Lombardi Ronald M.Director, Chief Executive Officer	Grant or award A	+39,904	–	355,776	Form 4
2025-05-05	Lombardi Ronald M.Director, Chief Executive Officer	Shares withheld for tax F	−19,294	82.98	336,482	Form 4
2025-05-05	Fritz Mary BethSVP Quality & Regulatory	Grant or award A	+1,602	–	18,107	Form 4
2025-05-05	Fritz Mary BethSVP Quality & Regulatory	Shares withheld for tax F	−741	82.98	17,366	Form 4
2025-05-05	P'Pool WilliamSee Remarks	Grant or award A	+2,562	–	21,379	Form 4
2025-05-05	P'Pool WilliamSee Remarks	Shares withheld for tax F	−1,314	82.98	20,065	Form 4
2025-05-02	Zerillo JeffreySenior VP Operations	Shares withheld for tax F	−394	84.19	41,130	Form 4
2025-05-02	Zerillo JeffreySenior VP Operations	Shares withheld for tax F	−425	84.19	40,705	Form 4
2025-05-02	Sacco ChristineCFO & COO	Shares withheld for tax F	−1,000	84.19	50,259	Form 4
2025-05-02	Sacco ChristineCFO & COO	Shares withheld for tax F	−1,091	84.19	49,168	Form 4
2025-05-02	Mekhail AdelEVP, Marketing & Sales	Shares withheld for tax F	−463	84.19	17,902	Form 4
2025-05-02	Mekhail AdelEVP, Marketing & Sales	Shares withheld for tax F	−505	84.19	17,397	Form 4
2025-05-02	Lombardi Ronald M.Director, Chief Executive Officer	Shares withheld for tax F	−2,664	84.19	318,288	Form 4
2025-05-02	Lombardi Ronald M.Director, Chief Executive Officer	Shares withheld for tax F	−2,416	84.19	315,872	Form 4
2025-05-02	Fritz Mary BethSVP Quality & Regulatory	Shares withheld for tax F	−307	84.19	16,850	Form 4
2025-05-02	Fritz Mary BethSVP Quality & Regulatory	Shares withheld for tax F	−345	84.19	16,505	Form 4
2025-05-02	P'Pool WilliamSee Remarks	Shares withheld for tax F	−544	84.19	19,414	Form 4
2025-05-02	P'Pool WilliamSee Remarks	Shares withheld for tax F	−597	84.19	18,817	Form 4
2025-03-03	Fritz Mary BethSVP Quality & Regulatory	Option exercise M	+6,297	44.33	25,132	Form 4
2025-02-11	Mekhail AdelEVP, Marketing & Sales	Option exercise M	+5,400	44.33	23,765	Form 4
2025-02-11	Mekhail AdelEVP, Marketing & Sales	Option exercise M	+5,683	54.47	24,048	Form 4
2025-01-06	Sacco ChristineCFO & COO	Grant or award A	+21,136	–	51,259	Form 4
2024-12-06	P'Pool WilliamSee Remarks	Gift G	−100	–	19,958	Form 4
2024-12-06	P'Pool WilliamSee Remarks	Gift G	+100	–	100	Form 4
2024-11-19	Lombardi Ronald M.Director, Chief Executive Officer	Option exercise M	+5,213	57.18	326,165	Form 4
2024-11-19	Lombardi Ronald M.Director, Chief Executive Officer	Option exercise M	+5,662	56.11	326,614	Form 4
2024-11-18	Lombardi Ronald M.Director, Chief Executive Officer	Option exercise M	+48,512	57.18	369,464	Form 4
2024-11-18	Lombardi Ronald M.Director, Chief Executive Officer	Option exercise M	+33,725	56.11	354,677	Form 4
2024-11-12	Fritz Mary BethSVP Quality & Regulatory	Grant or award A	+6,471	39.98	25,306	Form 4
2024-11-12	Fritz Mary BethSVP Quality & Regulatory	Grant or award A	+3,414	54.47	22,249	Form 4
2024-11-12	Mekhail AdelEVP, Marketing & Sales	Option exercise M	+5,565	44.33	27,428	Form 4
2024-11-12	Sacco ChristineChief Financial Officer	Option exercise M	+24,686	30.56	54,809	Form 4

How to read it

Buy, sale: Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan: A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after: The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value: Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Prestige Consumer Healthcare's scores and multiples ›